financetom
Business
financetom
/
Business
/
MAG Silver Files Preliminary Base Shelf Prospectus; Reported Q1 Earnings Earlier Tuesday
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MAG Silver Files Preliminary Base Shelf Prospectus; Reported Q1 Earnings Earlier Tuesday
May 14, 2024 1:23 PM

03:58 PM EDT, 05/14/2024 (MT Newswires) -- MAG Silver ( MAG ) , which earlier Tuesday reported first-quarter results, said shortly before the close of trade said filed a preliminary short form base shelf prospectus.

According to the latest statement, the filing is with the securities commissions in all of the provinces and territories of Canada. A corresponding registration statement will be filed with the United States Securities and Exchange Commission.

Upon the issuance of a receipt for the Final Shelf Prospectus and the filing of the Registration Statement with the SEC, the company will be permitted to offer up to US$250 million of common shares, preferred shares, debt securities, subscription receipts, units and warrants or any combination thereof during the 25-month period that the Prospectus is effective. The specific terms of any offering of securities, including the use of proceeds from any offering, will be set forth in a shelf prospectus supplement.

Securities may be offered under the Prospectus (and corresponding Registration Statement) separately or together, in amounts, at prices and on terms to be determined based on market conditions at the time of sale and as set forth in an applicable prospectus supplement. No Securities may be sold, nor may offers to buy be accepted, prior to the time a receipt for the Final Shelf Prospectus has been issued and the Registration Statement has been filed with the SEC.

Earlier Tuesday, MAG said its first-quarter profit more than tripled on higher returns from its 44% stake in the Juanicipio silver mine in Mexico. The company said it earned US$14.9 million, or US$0.14 per share, up from US$4.71 million, or US$0.05, in the year-prior quarter.

MAG shares were last seen up C$0.59 to C$17.56 on the Toronto Stock Exchange.

Price: 17.57, Change: +0.60, Percent Change: +3.54

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Microsoft Delays General Release of AI-Powered Activity Tracking Feature
Microsoft Delays General Release of AI-Powered Activity Tracking Feature
Jun 14, 2024
07:10 AM EDT, 06/14/2024 (MT Newswires) -- Microsoft ( MSFT ) said Thursday it will postpone the launch of its AI-powered Recall computer usage tracking feature amid privacy concerns. In an update to a blog item posted last week, the company said it will instead preview the feature with a small group. This decision is rooted in our commitment to...
Insurer Globe Life begins internal review after inquiry from regulator
Insurer Globe Life begins internal review after inquiry from regulator
Jun 14, 2024
June 14 (Reuters) - Insurance firm Globe Life ( GL ) has started a review of potential vulnerabilities that could have allowed unauthorized access to its customers' information after an inquiry from a regulator, the company said on Friday. (Reporting by Niket Nishant in Bengaluru; Editing by Janane Venkatraman ) ...
FAA investigating counterfeit titanium used in some Boeing and Airbus jets, NYT reports
FAA investigating counterfeit titanium used in some Boeing and Airbus jets, NYT reports
Jun 14, 2024
(Reuters) -The U.S. Federal Aviation Administration is investigating falsified documents that were used to verify the authenticity of titanium used in some recently manufactured Boeing ( BA ) and Airbus jets, the New York Times reported on Friday. The falsified documents are being investigated by the FAA and Spirit AeroSystems ( SPR ), which is a supplier to both Boeing...
Teva Pharmaceutical Sues Corcept Therapeutics Alleging Market Monopolization for Cushing's Syndrome Drug Korlym
Teva Pharmaceutical Sues Corcept Therapeutics Alleging Market Monopolization for Cushing's Syndrome Drug Korlym
Jun 14, 2024
07:19 AM EDT, 06/14/2024 (MT Newswires) -- Teva Pharmaceutical Industries ( TEVA ) has sued Corcept Therapeutics ( CORT ) , accusing the company of monopolizing the market for Korlym, a mifepristone-based drug used to treat Cushing's syndrome, according to the complaint filed with a federal court in San Francisco on Thursday. The lawsuit claims that Corcept, in collaboration with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved